WEDNESDAY, Jan. 8, 2014 (HealthDay News) -- A new kind of
implant may offer people suffering from sleep apnea an alternative
to wearing an air mask while they snooze, researchers report.
With the implant, a pacemaker delivers electrical impulses to a
nerve that controls the tongue and maintains the muscle tone of a
sleeping person's upper airway, according to a study published in
the Jan. 9 issue of the
New England Journal of Medicine.
These impulses reduced nightly sleep apnea events by about 68
percent, according to the results of the one-year clinical trial.
The technology also decreased by 70 percent the number of times
that a person's blood oxygen level dropped due to sleep apnea.
Not surprisingly, patients reported a 40 percent improvement in
their ability to stay awake during the day, the researchers
Sleep apnea is a disorder in which a person's breathing pauses
or grows shallow while they are asleep. The most common type is
obstructive sleep apnea, in which the person's airway collapses or
becomes blocked during sleep, according to the U.S. National Heart,
Lung, and Blood Institute.
Left untreated, the condition disrupts sleep and causes a person
to feel drowsy during the day. Long-term health consequences can
include heart disease, insulin resistance and high cholesterol,
said study author Dr. Patrick Strollo.
Doctors most often treat obstructive sleep apnea by asking
patients to use a continuous positive airway pressure (CPAP)
machine while they sleep, said Strollo, co-director of the Sleep
Medicine Institute at the University of Pittsburgh and director of
the university's Sleep Medicine Center.
With CPAP, patients wear a nose and mouth mask attached to an
motor, and the mild air pressure maintained by the pump keeps their
airway from collapsing -- much in the way that an air pump keeps an
inflatable holiday lawn decoration from flopping over.
However, some patients can't sleep with the CPAP mask on or they
find the air pressure uncomfortable, Strollo said.
"We always struggle in the field of sleep apnea to be able to effectively treat patients and present them with options," he said. "This represents a different option for patients that cannot tolerate CPAP."
In the clinical trial, 124 patients at 22 different hospitals in
the United States and Europe were fitted with a pacemaker in their
chest. The study was supported by the pacemaker's manufacturer,
Inspire Medical Systems. The company also helped design the study
alongside the researchers and regulators from the U.S. Food and
With the device, an electrode runs from the pacemaker to the
hypoglossal nerve located under the tongue. Another lead wire runs
down to the muscles between the ribs of the chest and keeps track
of the person's breathing.
The surgery is minimally invasive, and patients typically were
back to regular activity within a day or two, said study co-author
Dr. Ryan Soose, director of the division of sleep surgery at
"It's a unique and promising new treatment," Soose said.
As the patient breathes in and out, the pacemaker sends
electrical impulses to the nerve, which causes the person's tongue
to move slightly forward and their upper airway to contract open.
Both movements keep the airway from collapsing.
Patients only used the pacemaker during sleep, turning it on and
off by waving a magnet over the implant.
"We found there was a very robust effect on sleep apnea," Strollo said. Patients experienced much fewer episodes of sleep apnea and received much more oxygen in their blood as a result.
The researchers also found that sleep apnea returned when
patients were taken off the pacemaker treatment.
The technology also appears safe. It did no permanent damage to
the patient's tongues, Strollo said, although two of five patients
did report some discomfort associated with the electrical
In an accompanying journal editorial, Dr. Atul Malhotra at the
University of California, San Diego, noted that while the pacemaker
appeared to reduce sleep apnea, it didn't eliminate it. He pointed
out that the study lacked a comparison group, and that the results
could have been due to other factors such as participants' diet or
An FDA panel will review findings from the clinical trial in
February, Strollo said.
A number of teams have been researching this technology, said
Dr. William Kohler, medical director of the Florida Sleep
Institute. He was not involved with the new study.
Kohler sees the pacemaker technology as an alternative to CPAP,
rather than something that will supplant the air mask.
"This needs to be investigated as a treatment not in the first line, but if other treatments fail," Kohler said. "The more therapies we have out there, the better. But we need more experience with it to really see where it's going to fit as far as the overall treatment for sleep apnea goes."
To learn more about sleep apnea, visit the
U.S. National Heart, Lung, and Blood
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.